Akebia Therapeutics, Inc.Akebia Therapeutics, Inc.Akebia Therapeutics, Inc.

Akebia Therapeutics, Inc.

No trades
See on Supercharts

Price target

5.500.000.00%
The 3 analysts offering 1 year price forecasts for AKBA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 3 analysts giving stock ratings to AKBA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


AKBA EPS for the last quarter is −0.10 USD despite the estimation of −0.06 USD. In the next quarter EPS is expected to reach −0.06 USD. Track more of Akebia Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Akebia Therapeutics, Inc. revenue is expected to reach ‪49.57 M‬ USD. Check out Akebia Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, AKBA price target is 5.50 USD with a max estimate of 7.50 USD and a min estimate of 4.00 USD. Check if this forecast comes true in a year, meanwhile watch Akebia Therapeutics, Inc. stock price chart and keep track of the current situation with AKBA news and stock market news.